The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

5 Jan 2024 11:01

RNS Number : 8185Y
Panmure Gordon (UK) Limited
05 January 2024
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Gordon (UK) Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Velocys plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Velocys plc

(d) Date dealing undertaken:

04 Jan 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchase

100,000

0.00238 GBP

0.00238 GBP

1p ordinary

Sales

2,867,929

0.00246 GBP

0.00234 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

05/01/2024

Contact name:

Freddie Wooding

Telephone number:

+44 (0)2078 862 969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERKZGGMGKLGDZM
Date   Source Headline
27th Dec 201912:02 pmRNSPrice Monitoring Extension
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
16th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20197:00 amRNSDirectorate Change
28th Nov 20194:40 pmRNSSecond Price Monitoring Extn
28th Nov 20194:35 pmRNSPrice Monitoring Extension
13th Nov 20197:00 amRNSVelocys fulfils order for bio-jet project in Japan
12th Nov 20191:00 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSLongspur Research initiates coverage on Velocys
15th Oct 20194:41 pmRNSSecond Price Monitoring Extn
15th Oct 20194:36 pmRNSPrice Monitoring Extension
10th Oct 20197:00 amRNSNegative-emission fuel agreement
7th Oct 20197:00 amRNSChange of Registered Office
24th Sep 20193:23 pmRNSTurner Pope investor evening
19th Sep 20197:00 amRNSVelocys secures order for biorefinery licence
18th Sep 20197:00 amRNSInterim results
5th Aug 20195:12 pmRNSHolding(s) in Company
5th Aug 20194:59 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSHolding(s) in Company
2nd Aug 20194:24 pmRNSHolding(s) in Company
2nd Aug 20199:00 amRNSDisclosure re Directors' Participation in Placing
31st Jul 201912:36 pmRNSResult of general meeting and total voting rights
15th Jul 20197:00 amRNSFundraise of £7M. Project co-funding by BA & Shell
4th Jul 20199:34 amRNSBlock listing Interim Review
12th Jun 20191:45 pmRNSResult of AGM
21st May 20197:00 amRNSMailing of 2018 annual report and AGM notice
21st May 20197:00 amRNSAnnual Financial Report
15th May 20197:00 amRNSFinal Results
29th Apr 20197:00 amRNSSuccessful close-out of ENVIA JV
27th Mar 20197:00 amRNSTransfer of FT Reactors to Velocys from ENVIA
11th Mar 20197:00 amRNSInsurance settlement reached for ENVIA incident
12th Feb 20197:00 amRNSAmended Agreement with Red Rock Biofuels
4th Jan 201910:29 amRNSBlock listing Interim Review
24th Dec 20187:00 amRNSDirectors' Shareholdings
19th Dec 20187:00 amRNSSite secured for UK waste-to-jet-fuel project
17th Dec 20187:00 amRNSAppointment of Non-Executive Directors
22nd Nov 20187:00 amRNSHolding(s) in Company
20th Nov 20187:00 amRNSHolding(s) in Company
20th Nov 20187:00 amRNSHolding(s) in Company
13th Nov 20188:04 amRNSDirectorate Changes - Appointment of CEO and CFO
5th Nov 20187:00 amRNSConversion of Convertible Loan Notes
16th Oct 20184:40 pmRNSSecond Price Monitoring Extn
16th Oct 20184:35 pmRNSPrice Monitoring Extension
15th Oct 20187:00 amRNSStatement re Share Price Movement
27th Sep 20184:40 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
26th Sep 20187:00 amRNSInterim Results
12th Sep 201812:04 pmRNSHolding(s) in Company
10th Sep 20187:00 amRNSENVIA plant update
6th Sep 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.